Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.
Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Sadoun A, Muus P, Wandt H, Mineur P, Whittaker JA, Fey M, Daniel MT, Castaigne S, Degos L.
Fenaux P, et al.
Leukemia. 2000 Aug;14(8):1371-7. doi: 10.1038/sj.leu.2401859.
Leukemia. 2000.
PMID: 10942231
Clinical Trial.